MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

Search

Verastem Inc

Closed

7.54 -2.08

Overview

Share price change

24h

Current

Min

7.44

Max

7.75

Key metrics

By Trading Economics

Income

-73M

-99M

Sales

9.1M

11M

Profit margin

-876.339

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+92.31% upside

Dividends

By Dow Jones

Next Earnings

18 Mar 2026

Market Stats

By TradingEconomics

Market Cap

377M

Previous open

9.62

Previous close

7.54

Verastem Inc Chart

Past performance is not a reliable indicator of future results.

Related News

8 May 2025, 19:14 UTC

Major Market Movers

Verastem Ovarian-Cancer Drug Combination Gets FDA Approval -- Update

31 Dec 2024, 19:15 UTC

Major Market Movers

Verastem Shares Soar on FDA Priority Review of Cancer Treatment

Peer Comparison

Price change

Verastem Inc Forecast

Price Target

By TipRanks

92.31% upside

12 Months Forecast

Average 15.5 USD  92.31%

High 20 USD

Low 14 USD

Based on 7 Wall Street analysts offering 12 month price targets forVerastem Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

7 ratings

7

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Verastem Inc

There is no Profile data available for 2VS.SG.
help-icon Live chat